Global Haematology Launch Director: Access & Growth

C028 (FCRS = CH028) Novartis Pharma AG

Basel

Hybrid

CHF 155.000 - 287.000

Vollzeit

Vor 7 Tagen
Sei unter den ersten Bewerbenden

Erhalte mehr Antworten von Arbeitgebern

Versende in nur wenigen Minuten einen passgenauen Lebenslauf.

Benefits dieser Stelle

Hybrid work options
Parental leave (14 weeks)

Zusammenfassung

Novartis Pharma AG in Basel is seeking a Director International, Haematology to lead the cross-functional international launch and growth strategy for a priority myelofibrosis asset. You will translate the One Brand Plan into market-facing strategies, guide launch deliverables, and partner with priority markets, Regions, and global teams to maximise patient access and commercial success.

The role requires a track record of launching assets across lifecycle, strong leadership in complex markets,

Qualifikationen

  • Minimum 10 years of relevant experience across commercial, marketing, sales, launch strategy, medical affairs and/or value & access, with significant experience in oncology or haematology.
  • Advanced degree in business, life sciences, medicine or a related discipline.
  • Demonstrated success leading the commercialisation of an asset across the lifecycle, including pre-launch and launch, in both above-country and in-market settings.

Aufgaben

  • Launch strategy and One Brand Plan.
  • Own the International commercial launch strategy and co-lead the cross-functional One Brand Plan, defining strategic imperatives and priority opportunities for International markets.
  • Partner with priority markets and Regions to localise strategy, remove launch barriers, capture insights and establish a tiered support model.
  • Lead asset positioning, master story, core messages and differentiation strategy across commercial, medical and access stakeholders.
  • Drive segmentation, customer journeys, engagement planning, and go-to-market choices with cross-functional partners.
  • Maintain an integrated view of the myelofibrosis landscape; translate insights into strategic choices and agile response plans.
  • Lead launch governance, readiness reviews, KPI and launch tracking, investment prioritisation and communication to leadership.
  • Act as the International commercial partner for Value & Access, shaping payer value and country reimbursement preparation.

Kenntnisse

Launch strategy
Cross-functional leadership
Market access
Commercial excellence
People management

Ausbildung

Advanced degree in business, life sciences, medicine

Jobbeschreibung

Novartis Pharma AG in Basel is seeking a Director International, Haematology to lead the cross-functional international launch and growth strategy for a priority myelofibrosis asset. You will translate the One Brand Plan into market-facing strategies, guide launch deliverables, and partner with priority markets, Regions, and global teams to maximise patient access and commercial success.

The role requires a track record of launching assets across lifecycle, strong leadership in complex markets,

Hol dir deinen kostenlosen, vertraulichen Lebenslauf-Check.
oder ziehe deine Datei hierhin.
Similar jobs

Ähnliche Jobs, die dir auch gefallen könnten

Global Haematology Launch Director
Global Haematology Launch Director

Novartis • Basel

Hybrid
CHF 155.000 - 287.000
Director, Hematology CLS
Director, Hematology CLS

Novartis • Basel

Hybrid
CHF 155.000 - 287.000
Director, Hematology CLS
Director, Hematology CLS

C028 (FCRS = CH028) Novartis Pharma AG • Basel

Hybrid
CHF 155.000 - 287.000
Hybrid work options
Parental leave (14 weeks)
Global Oncology New Product Strategy Lead
Global Oncology New Product Strategy Lead

Incyte Corporation • Morges

Vor Ort
CHF 240.000 - 360.000
Director, Global Oncology Value & Access
Director, Global Oncology Value & Access

Biopharma Careers • Basel

Vor Ort
CHF 160.000 - 296.000
Novartis Life Handbook
Hybrid working options
14 weeks paid parental leave
+3
Strategic Medical Director, Hemato-Oncology Europe
Strategic Medical Director, Hemato-Oncology Europe

BeOne Medicines • Basel

Vor Ort
CHF 251.000 - 314.000
Executive Director, Global Immunology Value & Access
Executive Director, Global Immunology Value & Access

C028 (FCRS = CH028) Novartis Pharma AG • Basel

Hybrid
CHF 179.000 - 333.000
Hybrid working options
Parental leave (14 weeks)
Long-term equity awards
+4
Global Oncology Launch Director for Orphan Indication
Global Oncology Launch Director for Orphan Indication

GSK • Zug

Hybrid
CHF 146.000 - 211.000
Global Oncology Value & Access Director (Hybrid)
Global Oncology Value & Access Director (Hybrid)

C028 (FCRS = CH028) Novartis Pharma AG • Basel

Hybrid
CHF 160.000 - 296.000
Relocation support
Hybrid work options
Parental leave
Immunology Disease Area Lead Europe – Growth & Launch
Immunology Disease Area Lead Europe – Growth & Launch

Novartis • Basel

Hybrid
CHF 155.000 - 287.000
Insurance plans
Retirement plans
Wellbeing resources
+2